首页|乳腺癌患者不同病理特征中H3K9ac、PD-L1、VISTA表达及其联合检测对乳腺癌不良预后的预测价值

乳腺癌患者不同病理特征中H3K9ac、PD-L1、VISTA表达及其联合检测对乳腺癌不良预后的预测价值

扫码查看
目的 探讨乳腺癌患者不同病理特征中组蛋白H3第9位赖氨酸残基乙酰化(H3K9ac)、程序性死亡因子配体1(PD-L1)、T细胞激活抑制物免疫球蛋白的可变区结构域(VISTA)及其联合检测对乳腺癌不良预后的预测价值.方法 选取2018年5月至2020年7月平顶山市第一人民医院收治的130例乳腺癌患者,免疫组化检测乳腺癌组织及癌旁组织中H3K9ac、PD-L1及VISTA表达情况.比较乳腺癌组织、癌旁组织中H3K9ac、PD-L1及VISTA表达情况;比较乳腺癌不同病理特征中H3K9ac、PD-L1及VISTA表达情况;随访3 a,根据是否发生转移、复发、死亡分为预后不良和预后良好;比较预后不良和预后良好乳腺癌患者H3K9ac、PD-L1及VISTA表达情况;分析H3K9ac、PD-L1、VISTA表达联合检测对乳腺癌不良预后的预测价值.结果 乳腺癌组织中H3K9ac、PD-L1、VISTA高表达率均高于癌旁组织(P<0.05);不同组织分化程度、T分期、N分期、阳性淋巴细胞数目中H3K9ac、PD-L1、VISTA高表达率比较,差异有统计学意义(P<0.05);随访3 a,130例乳腺癌患者失访7例(5.38%),预后不良22例,预后良好101例.预后不良患者H3K9ac、PD-L1、VISTA高表达率高于预后良好患者(P<0.05);H3K9ac、PD-L1、VISTA联合检测预测乳腺癌患者不良预后的AUC为0.902,大于各指标单独预测的0.714、0.866、0.781(P<0.05).结论 乳腺癌患者癌组织中H3K9ac、PD-L1及VISTA均呈高表达,其高表达与分化程度、分期、淋巴细胞数目等病理特征相关,H3K9ac、PD-L1、VISTA联合检测对乳腺癌患者不良预后具有较高的预测价值.
Expression of H3K9ac,PD-L1 and VISTA in Different Pathological Features of Breast Cancer Patients and the Value of Their Combined Detection in Predicting Poor Prognosis of Breast Cancer
Objective To investigate the expression of histone H3 lysine residue 9 acetylation(H3K9ac),programmed death ligand 1(PD-L1)and V-domain immunoglobulin suppressor of T-cell activation(VISTA)in different pathological features of breast cancer patients and the value of their combined detection in predicting poor prognosis of breast cancer.Methods A total of 130 cases of breast cancer patients admitted to the First People's Hospital of Pingdingshan from May 2018 to July 2020 were selected.The expressions of H3K9ac,PD-L1 and VISTA in breast cancer tissues and adjacent tissues were detected by immunohistochemistry.The expressions of H3K9ac,PD-L1 and VISTA in breast cancer tissues and adjacent tissues were compared.The expressions of H3K9ac,PD-L1 and VISTA in different pathological features of breast cancer were compared.After 3 years of follow-up,the patients were divided into poor prognosis and good prognosis according to metastasis,recurrence and death.The expressions of H3K9ac,PD-L1 and VISTA in breast cancer patients with poor prognosis and good prognosis were compared.The predictive value of combined detection of H3K9ac,PD-L1 and VISTA expression for poor prognosis of breast cancer was analyzed.Results The high expression rates of H3K9ac,H3K4me3,H3K27ac,PD-L1,and VISTA in cancer tissues were higher than those in para-cancerous tissues(P<0.05).The high expression rates of H3K9ac,PD-L1,and VISTA were different among different tissue differentiation levels,T stages,N stages,and the number of positive lymphocytes(P<0.05).After 3 years of follow-up,among 130 patients with breast cancer,7 cases(5.38%)were lost to follow-up,22 cases had poor prognosis and 101 cases had good prognosis.The high expression rates of H3K9ac,PD-L1,and VISTA in patients with poor prognosis were higher than those in patients with good prognosis(P<0.05).The AUC of H3K9ac,PD-L1 and VISTA combined detection for predicting poor prognosis of breast cancer patients was 0.902,which was higher than the above indicators were detected separately 0.714,0.866 and 0.781(P<0.05).Conclusion H3 K9ac,PD-L1 and VISTA are highly expressed in the cancer tissues of breast cancer patients,and their high expressions are related to the degree of differentiation,stage and number of lymphocytes.The combined detection of H3K9ac,PD-L1 and VISTA has a high predictive value for poor prognosis of breast cancer patients.

breast cancerhistone H3 lysine residue 9 acetylationprogrammed death ligand 1V-domain immunoglobulin suppressor of T-cell activationprognosis

赵杰、陶璐、刘姗姗

展开 >

平顶山市第一人民医院病理科,河南平顶山 467000

乳腺癌 组蛋白H3第9位赖氨酸残基乙酰化 程序性死亡因子配体1 T细胞激活抑制物免疫球蛋白的可变区结构域 预后

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(18)
  • 8